Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Kopetz

Showing results (11-20 of 456) with videos related to

Pageof 46
Sort By:
Oncology (Williston Park, N.Y.)|February 21, 2009
Picking the right road for metastatic colorectal cancer patientsMichael Overman, Scott Kopetz
Journal of Surgical Oncology|March 11, 2019
Ongoing and future directions in the management of metastatic colorectal cancer: Update on clinical trialsShailesh Advani, Scott Kopetz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2021
Going with the Flow: The Promise of Plasma-Only Circulating Tumor DNA AssaysAlisha Bent, Scott Kopetz
Gastrointestinal Cancer Research : GCR|April 8, 2016
Clinical Applications of Liquid Biopsies in Gastrointestinal OncologyAnastasia Katsiampoura, Scott Kopetz
Targeted Oncology|September 5, 2020
Applying Precision to the Management of BRAF-Mutant Metastatic Colorectal CancerBenny Johnson, Scott Kopetz
Journal of Oncology Practice|September 22, 2010
Commentary: practice patterns and potential impact on quality measures for a practicing physicianCathy Eng, Scott Kopetz
Cancer Journal (Sudbury, Mass.)|June 25, 2016
BRAF-Directed Therapy in Metastatic Colorectal CancerKrittiya Korphaisarn, Scott Kopetz
Clinical Colorectal Cancer|April 10, 2010
The SRC family of protein tyrosine kinases: a new and promising target for colorectal cancer therapyChristopher Lieu, Scott Kopetz
Clinical Advances in Hematology & Oncology : H&O|June 4, 2014
Clinical biomarkers in colorectal cancerVan Morris, Scott Kopetz
Gastrointestinal Cancer Research : GCR|April 8, 2016
Novel Therapies in Development for Metastatic Colorectal CancerMichael S Lee, Scott Kopetz
Pageof 46

Showing results (11-20 of 456) with videos related to

Sort By:
Pageof 46
Oncology (Williston Park, N.Y.)|February 21, 2009
Picking the right road for metastatic colorectal cancer patientsMichael Overman, Scott Kopetz
Journal of Surgical Oncology|March 11, 2019
Ongoing and future directions in the management of metastatic colorectal cancer: Update on clinical trialsShailesh Advani, Scott Kopetz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2021
Going with the Flow: The Promise of Plasma-Only Circulating Tumor DNA AssaysAlisha Bent, Scott Kopetz
Gastrointestinal Cancer Research : GCR|April 8, 2016
Clinical Applications of Liquid Biopsies in Gastrointestinal OncologyAnastasia Katsiampoura, Scott Kopetz
Targeted Oncology|September 5, 2020
Applying Precision to the Management of BRAF-Mutant Metastatic Colorectal CancerBenny Johnson, Scott Kopetz
Journal of Oncology Practice|September 22, 2010
Commentary: practice patterns and potential impact on quality measures for a practicing physicianCathy Eng, Scott Kopetz
Cancer Journal (Sudbury, Mass.)|June 25, 2016
BRAF-Directed Therapy in Metastatic Colorectal CancerKrittiya Korphaisarn, Scott Kopetz
Clinical Colorectal Cancer|April 10, 2010
The SRC family of protein tyrosine kinases: a new and promising target for colorectal cancer therapyChristopher Lieu, Scott Kopetz
Clinical Advances in Hematology & Oncology : H&O|June 4, 2014
Clinical biomarkers in colorectal cancerVan Morris, Scott Kopetz
Gastrointestinal Cancer Research : GCR|April 8, 2016
Novel Therapies in Development for Metastatic Colorectal CancerMichael S Lee, Scott Kopetz
Pageof 46